Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kenvue, Inc. (KVUE)
NYSE:KVUE
Holding KVUE?
Track your performance easily
KVUE Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.67 - $24.31
Previous Close$24.08
Volume10.51M
Average Volume (3M)15.37M
Market Cap
$46.17B
Enterprise Value$53.81B
Total Cash (Recent Filing)$1.06B
Total Debt (Recent Filing)$8.70B
Price to Earnings (P/E)43.5
Beta0.48
Next Earnings
Feb 06, 2025EPS Estimate
$0.26Last Dividend Ex-Date
Nov 13, 2024Dividend Yield3.34%
Share Statistics
EPS (TTM)0.55
Shares Outstanding1,917,257,438
10 Day Avg. Volume14,844,323
30 Day Avg. Volume15,370,102
Standard Deviation0.09
R-Squared0.30
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)4.29
Price to Sales (P/S)2.94
Price to Cash Flow (P/CF)45.60
P/FCF Ratio43.40
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.48
Enterprise Value/Gross Profit6.23
Enterprise Value/Ebitda20.82
Forecast
1Y Price Target
$24.60Price Target Upside2.16% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering7
Kenvue, Inc. News
PremiumCompany Announcements
Kenvue Reports Third Quarter 2024 Financial Results
Bulls Say, Bears Say
Bulls Say
Market Valuation And Growth PotentialKVUE trades at a discount compared to peers, making its valuation attractive with expected multiple expansions.
Strategic Partnerships And InnovationManagement's strategy to improve the SH&B segment includes new partnerships with renowned dermatologists and product innovation, showing a commitment to long-term growth.
Transformational Growth And InvestmentKenvue is in the early stages of a transformation. A business that was run for cash is now being primed for growth.
Bears Say
Investor SentimentInvestors have grown impatient with KVUE's lackluster top line performance, leading to relative stock underperformance compared to industry peers.
Sales PerformanceSales were slightly below estimates, with a decline in the SH&B segment due to a weak sun season and decelerating skincare category.
Strategic ManagementMissteps in strategy and execution post-split from Johnson & Johnson suggest potential management and board changes may be necessary.
---
Ownership Overview
0.02% Insiders
37.44% Mutual Funds
13.68% Other Institutional Investors
24.59% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KVUE FAQ
What was Kenvue, Inc.’s price range in the past 12 months?
Kenvue, Inc. lowest stock price was $17.67 and its highest was $24.31 in the past 12 months.
What is Kenvue, Inc.’s market cap?
Currently, no data Available
When is Kenvue, Inc.’s upcoming earnings report date?
Kenvue, Inc.’s upcoming earnings report date is Feb 06, 2025 which is in 74 days.
How were Kenvue, Inc.’s earnings last quarter?
Kenvue, Inc. released its earnings results on Nov 07, 2024. The company reported $0.28 earnings per share for the quarter, beating the consensus estimate of $0.272 by $0.008.
Is Kenvue, Inc. overvalued?
According to Wall Street analysts Kenvue, Inc.’s price is currently Undervalued.
Does Kenvue, Inc. pay dividends?
Kenvue, Inc. pays a Semiannually dividend of $0.2 which represents an annual dividend yield of 3.34%. See more information on Kenvue, Inc. dividends here
What is Kenvue, Inc.’s EPS estimate?
Kenvue, Inc.’s EPS estimate is $0.26.
How many shares outstanding does Kenvue, Inc. have?
Kenvue, Inc. has 1,917,257,400 shares outstanding.
What happened to Kenvue, Inc.’s price movement after its last earnings report?
Kenvue, Inc. reported an EPS of $0.28 in its last earnings report, beating expectations of $0.272. Following the earnings report the stock price went up 2.108%.
Which hedge fund is a major shareholder of Kenvue, Inc.?
Among the largest hedge funds holding Kenvue, Inc.’s share is Yacktman Asset Management LP. It holds Kenvue, Inc.’s shares valued at 194M.
---
Kenvue, Inc. Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$24.60 (2.16% Upside)
$24.60 (2.16% Upside)
Blogger Sentiment
Bullish
KVUE Sentiment 92%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 770.9K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 3.3%
Last 30 Days ▲ 3.3%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
24.96%
12-Months-Change
Fundamentals
Return on Equity
9.88%
Trailing 12-Months
Asset Growth
-0.56%
Trailing 12-Months
Company Description
Kenvue, Inc.
Kenvue Inc is a pure-play consumer health company. It is a global leader at the intersection of healthcare and consumer goods, with a portfolio of iconic brands, operating in some of the most attractive categories in consumer health. The consumer health portfolio includes self-care, skincare and beauty and essential personal care products.
---
KVUE Company Deck
---
KVUE Earnings Call
Q3 2024
0:00 / 0:00
---
KVUE Revenue Breakdown
41.77% Self Care
29.88% Essential Health
28.35% Skin Health and Beauty
---
KVUE Stock 12 Month Forecast
Average Price Target
$24.60
▲(2.16% Upside)
Technical Analysis
Best Analysts Covering KVUE
1 Year
1 Year Success Rate
7/7 ratings generated profit
1 Year Average Return
+17.37%
reiterated a buy rating 17 days ago
Copying Susan Anderson's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +17.37% per trade.
---